These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2133089)

  • 1. The fecapentaenes, potent mutagens from human feces.
    Kingston DG; Van Tassell RL; Wilkins TD
    Chem Res Toxicol; 1990; 3(5):391-400. PubMed ID: 2133089
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and structure elucidation of fecapentaenes-12, potent mutagens from human feces.
    Hirai N; Kingston DG; Van Tassell RL; Wilkins TD
    J Nat Prod; 1985; 48(4):622-30. PubMed ID: 4045474
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General structure of "fecapentaenes"--the mutagenic substances in human faeces: a preliminary report.
    Bruce WR; Baptista J; Che T; Furrer R; Gingerich JS; Gupta I; Krepinsky JJ; Grey AA; Yates P
    Naturwissenschaften; 1982 Nov; 69(11):557-8. PubMed ID: 7155190
    [No Abstract]   [Full Text] [Related]  

  • 5. The precursors of fecapentaenes. A preliminary report.
    Van Tassell RL; Wilkins TD
    Ann Ist Super Sanita; 1986; 22(3):933-41. PubMed ID: 3826998
    [No Abstract]   [Full Text] [Related]  

  • 6. On distribution of different fecapentaenes, the fecal mutagens, in the human population.
    Baptista J; Bruce WR; Gupta I; Krepinsky JJ; van Tassell RL; Wilkins TD
    Cancer Lett; 1984 Apr; 22(3):299-303. PubMed ID: 6713371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecapentaene-12 causes DNA damage and mutations in human cells.
    Plummer SM; Grafstrom RC; Yang LL; Curren RD; Linnainmaa K; Harris CC
    Carcinogenesis; 1986 Sep; 7(9):1607-9. PubMed ID: 3742732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecapentaene concentration and mutagenicity in 718 North American stool samples.
    Schiffman MH; Van Tassell RL; Andrews AW; Wacholder S; Daniel J; Robinson A; Smith L; Nair PP; Wilkins TD
    Mutat Res; 1989 Apr; 222(4):351-7. PubMed ID: 2649794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model study of fecapentaenes: mutagens of bacterial origin with alkylating properties.
    Gupta I; Suzuki K; Bruce RW; Krepinsky JJ; Yates P
    Science; 1984 Aug; 225(4661):521-3. PubMed ID: 6377497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces.
    Gupta I; Baptista J; Bruce WR; Che CT; Furrer R; Gingerich JS; Grey AA; Marai L; Yates P; Krepinsky JJ
    Biochemistry; 1983 Jan; 22(2):241-5. PubMed ID: 6824628
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory and epidemiologic studies of fecapentaenes.
    Povey AC; Schiffman M; Taffe BG; Harris CC
    Mutat Res; 1991; 259(3-4):387-97. PubMed ID: 2017218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fecapentaenes on nuclear aberrations in murine colonic epithelial cells.
    Vaughan DJ; Furrer R; Baptista J; Krepinsky JJ
    Cancer Lett; 1987 Oct; 37(2):199-203. PubMed ID: 3677054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecapentaenes and their precursors throughout the bowel--results of an autopsy study.
    Schiffman MH; Bitterman P; Viciana AL; Schairer C; Russell L; Van Tassell RL; Wilkins TD
    Mutat Res; 1988 May; 208(1):9-15. PubMed ID: 3367931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets.
    de Kok TM; van Faassen A; Bausch-Goldbohm RA; ten Hoor F; Kleinjans JC
    Cancer Lett; 1992 Feb; 62(1):11-21. PubMed ID: 1540928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12.
    Kleinjans JC; Pluijmen MH; Hageman GJ; Verhagen H
    Cancer Lett; 1989 Jan; 44(1):33-7. PubMed ID: 2917340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the genotoxicity of fecapentaenes.
    Nair PP; Shami S; Sainz E; Judd JT; Taylor PR; Schatzkin A
    Mutat Res; 1991 Jun; 260(2):153-7. PubMed ID: 1904547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fecal mutagenicity and colorectal cancer risk.
    de Kok TM; van Maanen JM
    Mutat Res; 2000 Jul; 463(1):53-101. PubMed ID: 10838209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative HPLC analysis of the level of fecapentaenes and their precursors in human feces by a chemical conversion method.
    Kivits GA; de Boer BC; Nugteren DH; van der Steeg M; Vertegaal LB; van der Gen A
    J Nat Prod; 1990; 53(1):42-9. PubMed ID: 2348203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines.
    Van Tassell RL; Kingston DG; Wilkins TD
    Mutat Res; 1990 May; 238(3):209-21. PubMed ID: 2160606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial biosynthesis of fecapentaenes.
    Van Tassell RL; Schram RM; Wilkins TD
    Prog Clin Biol Res; 1986; 206():199-211. PubMed ID: 3952090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.